<SEC-DOCUMENT>0001213900-20-020802.txt : 20200807
<SEC-HEADER>0001213900-20-020802.hdr.sgml : 20200807
<ACCEPTANCE-DATETIME>20200807104010
ACCESSION NUMBER:		0001213900-20-020802
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200805
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200807
DATE AS OF CHANGE:		20200807

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OptimizeRx Corp
		CENTRAL INDEX KEY:			0001448431
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				261265381
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38543
		FILM NUMBER:		201084243

	BUSINESS ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
		BUSINESS PHONE:		248-651-6558

	MAIL ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea125181-8k_optimizerxcorp.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WASHINGTON,
D.C. 20549<BR></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 13 OR 15(d) OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES EXCHANGE ACT OF 1934<BR>
<BR>
</B>Date of Report (Date of earliest event reported): August 5, 2020<BR>
<BR>
<U>OptimizeRx Corporation</U><BR>
(Exact name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38543</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26-1265381</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction <BR>
of incorporation)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
    <BR>
File Number)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer <BR>
Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 66%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400
    Water Street, Suite 200, Rochester, MI</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48307</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
telephone number, including area code: <U>248.651.6568</U></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 60%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(Former name or former address, if changed
since last report)</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 96%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company&nbsp;&nbsp;&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of each class</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
    symbol</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of each exchange on which registered</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPRX</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
    Capital Market</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8 &ndash; Other Events</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
8.01 Other Events</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 5, 2020, we held a conference call to discuss our 2020 second quarter earnings and other matters of business, a transcript
of which is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in Item 8.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed &ldquo;filed&rdquo; for
purposes of Section 18 of the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange
Act, except as expressly set forth by specific reference in such a filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9 &ndash; Financial Statements and Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
9.01 Financial Statements and Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD><A HREF="ea125181ex99-1_optimizerx.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conference call transcript dated August 5, 2020</FONT></A></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OptimizeRx
Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Doug Baker</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doug
    Baker<BR>
    Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    August 7, 2020</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea125181ex99-1_optimizerx.htm
<DESCRIPTION>CONFERENCE CALL TRANSCRIPT DATED AUGUST 5, 2020
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 19px"></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C
O R P O R A T E P A R T I C I P A N T S</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo, </B><I>Chief Executive Officer &amp; Director</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Douglas
Baker, </B><I>Chief Financial Officer</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stephen
Silvestro, </B><I>Chief Commercial Officer</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miriam
Paramore, </B><I>President</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;&nbsp;</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C
O N F E R E N C E C A L L P A R T I C I P A N T S</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ryan
Daniels,</B> <I>William Blair &amp; Company</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D'Silva,</B> <I>B. Riley FBR, Inc.</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi,</B> <I>Lake Street Capital Markets</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Richard
Baldry,</B> <I>ROTH Capital Partners</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alex
Silverman,</B> <I>AWM Investment Company</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Harvey
Poppel,</B> <I>Poptech, LP</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Josh
Goldberg,</B> <I>G2</I></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>P
R E S E N T A T I O N</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Good
afternoon, and thank you for joining us today to discuss OptimizeRx Corporation's second quarter ended June 30, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
us today are the Company's Chief Executive Officer, William Febbo; Company President, Miriam Paramore; Chief Financial Officer,
Doug Baker; and Chief Commercial Officer, Stephen Silvestro. Following Management&rsquo;s remarks today, we'll open the call to
questions. And before we conclude today's call, I'll provide some important cautions regarding the forward-looking statements
made by Management during the call.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I'd
like to remind everyone that today's call is being recorded, and will be made available for telephone replay via instructions
on today's press release in the Investors section of the Company's website.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
I'd like to turn the call over to OptimizeRx CEO, William Febbo. Please go ahead.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex99-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Lisa.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Good
afternoon, everyone. Thanks for joining us on the call today.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Well,
only a few months have passed since we last spoke on May 4. So many things had happened around us all. The disruption of everyone's
day-to-day is actually hard to capture in words, but we all feel it. I hope all our listeners are in good health. The team at
OptimizeRx is healthy, focused and very grateful to have as many opportunities as we do to scale our business in this environment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
started the previous conference call by thanking all the health care professionals for their commitment and bravery. I want to
say it again: thank you very much. We at OptimizeRx consider ourselves very fortunate during the pandemic to be an instrumental
conduit of communication between the industry, doctors and patients. We are focused on delivering value for all our stakeholders.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
support that statement, we grew at a faster pace than we anticipated, 34% for the first half of 2020, traditionally our slower
half. We expect second half to far exceed this growth rate. We closed additional enterprise deals, bringing the total value of
our enterprise level engagements to $21 million in annualized revenue. We expanded our network reach with an additional 125,000
doctors by connecting into Epic and Cerner. We secured revenue from five clients for new solutions borne out of our Innovation
Lab, which sets us up nicely for 2021. We also fine-tuned our patient engagement market strategy at a time when demand has never
been greater due to COVID.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
short, we beat our internal goals across the board, and we continue to build a highly impactful Company situated smack in the
middle of all stakeholders. Our digital communication platform helps doctors, patients and the industry do what we are all in
it for and that is to improve health in an affordable way.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
before I go further, I'd like to turn the call over to our CFO, Doug Baker, who will walk us through the financial details for
the second quarter. I'll then return to discuss more on how we are winning business and our outlook for the rest of the year.
And then I will open it up to questions. Once again, we have our full Executive team on the call today to help with any of your
questions.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doug,
take it away.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Douglas
Baker</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Will, and good afternoon, everyone.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earlier
today, we issued a press release with the results of our second quarter that ended June 30, 2020. A copy is available for viewing
and may be downloaded from the Investor Relations section of our website. We also filed a copy of our 10-Q with the SEC a short
time ago, and that is also available at sec.gov.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue for the quarter was a record $8.8 million, up 25% compared to the year-ago quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
margin was $5.1 million, up 19% versus a year ago. Our gross margin percentage declined to 59% in the second quarter of 2020 versus
a year ago, but was improved over the first quarter of this year. The decline from last year was a result of an unusually favorable
product mix in the (audio interference) 2019 quarter and a heavier mix of financial messaging this quarter. We expect to achieve
a minimum gross margin of 60% for the year, but are targeting a gross margin of at least 62% by the fourth quarter.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;<IMG SRC="ex99-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operating expenses increased to $6.2 million in the second quarter of 2020 compared with the same quarter of 2019, but decreased
from $6.6 million in the first quarter of this year. The decrease largely reflects the reduction in travel as well as other related
expenses given the stay-at-home policy.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
investment in our commercial organization led to the 25% increase in revenue, a shift towards enterprise contracts and the decreased
sales cycle. Our investment in our marketing and product teams gave us the ability to be nimble and quickly respond to some of
the operational items that Will is going to discuss later in this call.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
EBITDA, which we report as a non-GAAP financial measure, was a positive $254,000 in the second quarter. It is great to be back
in the black, and we expect that to continue to increase for the rest of the year.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
balance sheet remains strong. Cash and cash equivalents totaled $14.1 million, down from $15.2 million at March 31. The decrease
resulted from the earnout payment related to our CareSpeak acquisition, but we were operationally cash flow positive for the quarter.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
receivables are very high-quality receivables because of our customer base. While they are increasing because of our strong revenue
growth and customer payment terms, our customers continue to pay regularly and predictably. We expect to generate positive cash
flow from operations in future quarters and for the full year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have continued to operate debt-free and do not anticipate needing to raise additional capital in the foreseeable future either
for operating purposes or to fund our growth plans.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
wraps up our discussion of our financial results. I'd like to turn the call back over to Will. Will?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Doug. Appreciate that.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
I will provide the caution that we are all on new ground when it comes to the level of continued disruption due to COVID-19, at
OptimizeRx we are fortunate to be so well situated in the market and able to affect digital communication among our stakeholders.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
terms of business continuity, our teams are operating very well, and we continue to see practically no disruption in operations.
We had a great start to the year across the board, and my hat is off to the team, and really glad to be connected with our clients
and partners. Our first half is traditionally the slower half of the year, and we expect this to hold true again this year, even
given the 34% increase. This means we shall see accelerating growth in the second half along with positive cash flow, as Doug
mentioned.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
focus on three main drivers for growth: our clients, our partner network and our digital health solutions. We digitally enable
communication which benefits patients and doctors around therapeutic awareness, affordability and adherence. Even prior to COVID,
we were feeling tailwinds to support growth in all three areas. COVID-19 has accelerated those tailwinds, and we have a very positive
outlook for the remainder of '20 and into '21.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First,
our clients. We&rsquo;re seeing terrific traction on multiple levels. Our shift to enterprise agreements is going exceedingly
well: as we mentioned, $21 million in annualized revenue. Our new solutions, like patient engagement, hub enrollment, TelaRep,
are all generating interest and revenue within our client base, which will drive further growth this year and very strong growth
next year. COVID has disrupted traditional non-digital ways of communication for our clients with doctors and patients; we stand
as a perfect solution to solve for that in the coming years.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;<IMG SRC="ex99-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
of our growth for the year is coming from organic activity as we see our pharma clients leaning into point-of-care as a critical
piece to their marketing strategy. We came in ahead of our internal budgets for the first half, and we expect to far exceed our
goals, as we had said earlier, for the second half.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
visits continued to be challenged in Q2, and we expect that to hold true through the summer in hotspots around the country and
possibly again later in the year. However, in regard to the impact on our business, the providers are still using their EHRs from
home to treat patients. It's also important to remember that we focus on essential medications, not elective; so, similar to Q1,
we did not see a material drop in e-prescribing in Q2.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also feel we have some strong tailwinds at our back in terms of our client base. Most of our clients have decided to proceed with
their new launches of brands. This is due to the complexities in costs around preparation and as part of the overall strategy
designed to prevent any substantial disruption. Medical conferences, medical liaisons, live advisory boards have all been disrupted
or gone virtual, so we expect this to drive an increase in demand for digital communication that delivers mission-critical information
at the point-of-care.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
course, we're thrilled with our 34% increase in revenue growth for the first half, but perhaps more importantly, we have seen
our close rate increase above 50%, and our sales cycle continues to be considerably shorter than the previous-year period.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
second driver of growth is our network of partners - and were we busy there. We are seeing more rapid adoption of digital tools
for doctors to combat the disruption of COVID. Macro trends are in our favor as highlighted by the rapid adoption of telehealth
and other digital tools. A clear theme forming is the need for the appropriate digital tools for doctors to maintain their practices
as such drastic disruptions appear. This allows our solution to be highlighted as an effective tool set up to deliver care to
patients. Of note, we integrated with new partners like Change Healthcare, Cerner and Epic which extends our reach further into
the point-of-care with over 125,000 additional doctors, a significant add to our network.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We're
making terrific traction with additional access to patients, enhancing our ability to affect adherence and affordability. We now
reach, via 10 hospital systems, some 15 million patients at the point of discharge. In the third quarter, we expect to gain considerably
more access to patients with additional partnerships with direct digital connection to patients.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Innovation Lab was very timely, and is producing strong receptivity in the market. We continue to believe that the Lab will allow
us to capture more EHR partners as well as additional channel partners within hub services, telehealth, appointment enablement
and retail pharmacy. Hub enrollment closed five clients, TelaRep is getting a lot of attention, and we anticipate additional revenue
from those short-term, but clearly setting us up for nice growth in '21.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
many of our channel partners already had telehealth solutions, the adoption had been relatively low. The recent increase in demand
for these types of service has been fantastic for all. But for us, it's implied a benefit that our channel partners are increasing
their attention towards these essential tools. Affordability and adherence has also moved up the priority list. As a result, the
discussions that we're progressing in normal speed are now accelerating with partners.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third level of growth is enhancements to our core solutions as well as new solutions. As our core solutions continue to scale,
we're seeing an increased demand, not only for financial messaging, but also brand and therapeutic support messaging as we enter
the second half.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
the unemployment levels, cost has again surfaced as a major problem for patients, and we expect those trends to continue. We've
also seen pharma reps continue to work from home and health conferences moving to virtual-only. These are drivers for demand for
what we do in terms of our digital delivery. We saw gross margin come up in Q2 as the growth in the messages in patient engagement
kicked in. We expect to see much more of that in Q3 and Q4, bringing our gross margin up to where we expect it on an annual basis.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I'm
very proud to share that we've taken one of our patient engagement clients beyond $1 million a year in revenue for 2020. COVID
has put a lot more attention within our client base on effective, compliant and transparent digital technologies that enable patient
engagement. We are very well situated to start to scale this part of our business with multiple clients and a very strong team.
These solutions are almost all recurring revenue and build nicely into 2021 as we complete the technology integration.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It's
important to keep in mind why OptimizeRx has such a strong, sustainable competitive advantage, a critical piece to the future
of the Company: we have a digital platform that brings together a very fragmented market of healthcare information technology,
connecting patients, doctors and manufacturers. We have the ability to connect all stakeholders in health care in a way that fits
into their daily lives and touches on the pain points we have all experienced, which include awareness, affordability and adherence
of our medications just to stay healthy.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are well positioned to bring frequent and measurable and very impressive return on investment for our clients. We have built meaningful
physician reach over the years and some measure of exclusivity by integrating our platform into the leading EHRs and e-prescribe
systems. As many of you know, today, we reach over 60% of the ambulatory market where most of prescribing happens.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We're
deeply entrenched in our client base as we work with 45% of the top 20 brands by revenue and have increased interest from the
remaining 55%. Our clients have multiple siloed businesses in need of our services, so we are focused on a land-and-expand strategy,
and are confident our growth in the second half will yield favorable results. The trust we've gained from our clients at a time
when digital communication is absolutely needed is supporting our continued shift to enterprise-level recurring revenue model.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also sit squarely in one of the fastest-growing segments in health technology that is point-of-care communications, where there
is tremendous client demand for greater connectivity that's effective, transparent and measurable. Our addressable market continues
to expand beyond the billions we have discussed with a clear shift coming from the sales rep and conference spend to digital communications.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
now live in the digital age, so we strive to be the best digital platform for everyone to work with. Today, we have a scalable
and secure technology to support and protect our growth. So when a doctor and a patient are working together to solve health issues,
we can be there and impactful.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fostering
a great culture continues to be a top priority, which, as any great leader or savvy investor knows, is an essential for making
a company great. People invest in people. We saw widespread unrest around racism in our country, and I want to assure my team,
our clients, our partners, our investors, we're absolutely dedicated to an open work environment where all are treated equally.
As a result, we formed an internal group to focus on our policies and practices to assure we all have the best possible work environment.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
with that, we'd like to open it up to your questions, which is always my favorite part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operator?</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you, sir.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you would like to ask a question please signal by pressing star, one on your telephone keypad. If you are using a speaker phone
please make sure your mute option is turned off to allow your signal to reach our equipment. Again please press star, one to ask
a question. We will pause for a moment to allow everyone an opportunity to signal.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
right. We'll take our first question from Ryan Daniels with William Blair.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;<IMG SRC="ex99-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Ryan
Daniels</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hi,
guys. Thanks for taking the questions. Congrats on all the momentum you&rsquo;re seeing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maybe
let me start with a bit of a housekeeping one. Gross margin, you discussed being a little bit lower year-over-year due to product
mix, but confident that will get to 63%. If I could do some quick math, it looks like if you're on 63% for the full year, you're
going to be in the mid to high 60s over the next few quarters. Is that correct? Or did you mean 63% by the year-end?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You're
pretty far from the mic, I think, Ryan, but I think I got it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doug,
do you want to answer that question?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Douglas
Baker</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sure.
Well, we're talking about year-end. Our goal is to get there for the full year, but at the minimum, we think we can get there
by fourth quarter or so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ryan
Daniels</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
And if we think about the growth outlook...</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ryan?
Can you get closer to the mic? Sorry, I'm not hearing you so well.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ryan
Daniels</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Can
you hear me better now? I'm closer to the mic.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
Thank you. That's great.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ryan
Daniels</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
All right. You talked about accelerating revenue in the back half of the year, and I know you don't want to explicitly give guidance.
But how should we think about the cadence in the back half of the year versus the first half in regards to overall organic revenue
growth?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It's
important to remember, pharmaceutical&mdash;what we're doing is a business-to-business solution. The pharmaceutical manufacturers
don't flip switches, and no one anticipated this disruption entering the year. So what they really used the first half for was
to carry on normal business, which is what we're seeing in these numbers, and then come up with strategies to pivot for the second
half.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you just tracked our normal business I think we probably wouldn't use the word accelerated. But because we're seeing a need to
connect with physicians and patients, which has really compounded year-over-year, we feel like we can use the word accelerated.
Obviously, we're saying 34% was our slow quarter. We're not going to give a number, but we're very encouraged with what we have
in front of us and closed and then what we always know comes in the form of additional business in the latter half of the year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ryan
Daniels</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sure.
And do you think the additional business, kind of the leftover marketing funds that could go digital because it's quicker to implement
that, could be greater than in years past? So you may even see more of a Q4 boost than you have, given what's going on with COVID
and the lack of conferences and other advertising venues, to manufacturers in particular?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steve,
do you want to take that one?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stephen
Silvestro</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sure,
Will. Hi, Ryan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
I think already then, we've seen a meaningful pivot in budget towards digital spend. Many of the conferences as well as sort of
deployment of sales reps have pivoted into digital enablement, focusing on driving sort of, as Will said earlier in the script,
point-of-care communication. And we've seen that across the board. I think the confidence interval that we've got for the second
half is largely based on our visibility to the second half. For us, sales is a leading indicator of revenue. So we have a little
bit more visibility on the sales side than we do on the revenue side.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
feel extremely confident that we'll see outsized growth in the second half just based on what we are seeing in those pivots, conversations
that we're engaging on sales that we've made and a pipeline that is certainly accretive to anything that we've seen previously.
So, feeling very good.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
And Ryan, I would just add to that that it might be sort of twofer. Right? You're going to get the normal buyouts, which we see.
Even in bad years you see them. And then there could be an additional shift from traditional non-digital budgets to the digital.
So I think across the board, with our peers as well, we'll see some of that.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ryan
Daniels</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
Great. Maybe two more quick ones. Just in regards to the enterprise pipeline, congrats on all the momentum there: six deals, about
$21 million or more in ECV (phon). How much of that do you think you'll actually be able to implement and see in 2020 versus how
much we should think of that being kind of a head start on the 2021 sales revenue?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will see most of that in 2020. And it is&mdash;again, let's go through it, right? The beauty of that business is, one, it is generally
annual in nature. It also sets you up for the next year really nicely. It's much stickier. And so yes, that is revenue we will
see this year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex99-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ryan
Daniels</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
year. Okay. And then maybe for Miriam, just I want to get a little bit more discussion on how far off you are on the relationship
that takes you into the 300 Cerner and Epic systems. Can you talk a little bit about that integration, how it's progressing and
what the potential revenue opportunities could be as you tap into the acute care market more actively?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miriam
Paramore</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
Hi, Ryan. This is Miriam.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I'll
take the channel partner side, and then, Steve, I'll let you speak to the revenue opportunity from the hospital space.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
started last year with our first sort of toe dipping into the acute care marketplace with a couple of different channels. And
this new one that we added gives us access, embedded access, native access to those health systems that we mentioned in the release
and Will talked about earlier.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We're
in the integration stages right now, Ryan, and we'll begin a rollout schedule. There's a little bit of good news, bad news on
the rollout. It's partially some of these health systems are cloud, some of them are not cloud. So there's no single switch to
flip to get everybody on at the same time. But what we're seeing is that in these new solutions, we'll have both point-of-discharge
capability as well as the point-of-prescribe capability as part of the real-time benefits check and showing that total out-of-pocket
impact. So it's a very impactful time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It&rsquo;s
really, really early. We're just getting started integrating, and those capabilities will be rolling out, I would expect for us
to be delivering solutions in Q4 this year. We're supposed to have integration finished with that channel. Our plan is by September,
but it's really, really early.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steve?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stephen
Silvestro</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
Thanks, Miriam.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ryan,
on the revenue side for the model, I mean we obviously don't have a lot of red in the number, but just Will shared earlier that
we've got 45% penetration with optimum brands by sales. We sort of think about that in sort of two future lenses: one with the
top 20 brands by sales, so we look at sales numbers; we also look at volume, or penetration by sales by volume.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you think about what Epic and Cerner and these integrations pipelines into those spaces will do, it will give us significant boost
and expansion to those brands that we've not yet entered into. And I think strategically, when we contemplate the network of networks
that we've got, we look at the brands that we have live on the platform, we look at access. Obviously, we're measuring that by
NPI, or by number of physicians, that we have where the platform is reaching. And then we look at areas where we're deficient,
and we're going to use that as a strategic map to go out and to work the channel.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
will have a significant impact, in my opinion, on the brands that are not currently live. In addition to that is, it will bolster
the volume of messaging and ability to communicate with existing brands that are on the platform. So as we increase those NPIs,
it ultimately means more messages which correlates to more revenue for the business. So hopefully, that helps out in your modelling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ryan
Daniels</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
very helpful. Thank you, and congrats on all the momentum. Wishing you guys all the best. Thank you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex99-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We'll
take our next question from Andrew D'Silva with B. Riley FBR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D'Silva</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hi.
Good afternoon, and congrats on all the progress. Just a few quick ones from me.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
start, I'm just kind of curious, as you look at the growth that you're expecting in the second half of the year, how much of that
is tied to contracts that you've already won throughout the first half of the year or year-to-date specifically versus new initiatives
that you expect to come on in the back part of the year?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">And
then are you still seeing additional off-cycle RFPs coming in currently, or has that largely stopped at this point?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hi,
Andy. Good to hear your voice. Hope you&rsquo;re well.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
we were being obviously very communicative on additional growth on second half because we've got some visibility, good visibility.
So it's business closed and in hand. We do anticipate additional business coming in that we just don't foresee, which is buy up.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">And
keep in mind, we're entering RFP season, which is the time when we're going to our clients proactively and showing them what we
can do for them next year. So lots going on, but have good visibility on what's in it for this year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">And
repeat your second question for me.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D'Silva</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No,
you answered it. Yes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay,
got it. Okay. Good.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D'Silva</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accidentally.
You&rsquo;re still great at doing that.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">And
if we're thinking about just life science clients in general, I know right after the largest swap of shutdowns took place in late
Q1, everybody was primarily virtual. Has that at least shifted a little bit where you're seeing some sales reps being able to
access physicians in person, or is it really status quo and still completely primarily virtual at this point?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
it's still virtual. And as a matter of fact, in some of my personal discussions with clients, I was given a 4% to 12% effective
rate by phone. So they're not doing any in person unless there's a surgery involved or some such. But the kind of reps that we
would be dealing with and the medications we deal with, still completely virtual. They moved to training on the phone, using any
means possible to connect. You have to remember, it's not well understood. Many doctors reach out to reps with specific questions,
right? So this has been highly disruptive, not only for pharma, but also for doctors.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex99-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">And
that's a big reason why we feel strongly about TelaRep, which just to remind the audience, that's the ability within the workflow
of the HR for the doctor to reach out to the rep. And we are the only company with that solution in the workflow. We certainly
have big CRMs that have solutions outside the workflow, but we're right in there.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
put those two together, and I think it's timely. I think we're seeing a prolonged disruption with the rep space. And just to remind
the audience, that's a $15 billion to $18 billion spend a year for pharma. So really significant disruption. Again, it's one of
the tailwinds for us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D'Silva</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
that's interesting. And obviously, very good results in the platform you've built over the last several years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Just
news flow in the industry has been quite interesting. Just today, you had Teladoc and Livongo&mdash;the Teladoc acquisition of
Livongo, actually. So is that&mdash;how do you view that M&amp;A? And&mdash;but if you kind of think about the different parts
that OPRX has put together to create the platform over the last five-or-so years, it seems to have some overlap now with what
Teladoc is attempting to do.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Can
you maybe think or describe how you're viewing their platform versus your platform and where each of you maybe fit into the broader
landscape?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
First off, thrilled for both companies. They're excellent companies that were early innovators, have really executed. So I think
there's a good cultural fit there. They're both companies that were focused on employers, right? They're trying to bring down
the cost of health care for employers and using digital means to do that. So you're combining a digital therapeutic with a telehealth
platform, and you can read the recent reports out there on some of the synergies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
focus on pharma and patients and doctors, right? So we're in a different piece of the industry, but it's the same idea: we're
enabling critical communication to help deliver care that's more affordable and people adhere to. They are delivering to employers
the value proposition that they can facilitate any involvement, actually have a protocol to help bring up adherence, in particular,
in diabetes, which is a big problem for most employers. And so a different side of the world, but two great companies that have
shown scale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
motivates us because we're obviously a young company, public, which still has the potential to build to be a business their size.
And so the investment thesis, we're sort of that one that shouldn't be public, but we are. And so when I see these kind of deals,
it really motivates me that the market will reward it. And then you can deliver a real company, a real strong digital health company,
which it's been a long time since we have a couple of those.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D'Silva</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
It's a really interesting campus that's being created right now.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Last
question for me. Could you just give a little bit of additional color on the collaboration with Change Healthcare and how different
than maybe some of the other partnerships you established? Or the same? I really just want to get a better understanding of what
it could mean for you going forward.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex99-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miriam
Paramore</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
Andy, this is Miriam.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
collaboration with Change is remarkable in the sense that they're one of the first, and maybe the first, partner who has enabled
all of our solutions from the very beginning. We have multiple messaging solutions in our core solutions. We have TelaRep and
our new smart button, Internet of Things kind of solution set, and they're enabling that as well, and we have patient engagement
solutions as well. So to have a partner that kind of turnkeys and that we can wide up on all signals is something that we've been
building towards because we have some partners, legacy partners who are from the original set of solutions and are gradually adding
our new solution set.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It&rsquo;s
very exciting to get into a book of business, a book of providers that can use all of our solutions from the beginning. We're
in the integration process right now.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
with that being said, it is, to set expectations, a relatively small number of prescribers associated with that. It's measured
in the thousands versus the tens of thousands. But it is the clinical interface that Change Healthcare has in their portfolio
and (Inaudible) I know really well from working there in prior years as part of the Management team.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It&rsquo;s
a great place to start. And then there are, of course, a lot of solutions within the Change Healthcare ecosystem, and we're continuing
to look for other opportunities to branch out. I hope that helps.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D'Silva</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
useful. Yes, no, very useful. Thank you very much. And great execution year-to-date, and good luck closing out the year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miriam
Paramore</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Andy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We'll
take our next question from Eric Martinuzzi with Lake Street.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
wanted to drill down on the enterprise deals. So just a quick math on the $21 million, and I think it's roughly six deals we're
talking about, about $3.5 million in annualized contract value there for each of those enterprise deals. My assumption here is
that people kind of&mdash;they become aware of OPRX because of the messaging; probably in most cases, financial messaging capability.
And then they add a second and a third product. So let me ask the question rather than answer that.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">What
are most people starting with? And then what are most people expanding into in the product suite?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
I mean that's a correct assumption. We've gained credibility through delivering very strong ROI with the financial messaging product.
It's also the one that reaches through all of our network, 100% of the network. So it's the lead horse, and it's come back pretty
strong.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT="">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">But
remember, in the enterprise, you go and you help the client think through the patient journey and who and when and how they want
to communicate with health care practitioners and patients. And so when we go back to an enterprise, it has multiple solutions.
It almost always has financial&mdash;in some cases, it won't, but almost always does. And Steve and his team have just done a
terrific job layering in those additional solutions. Particularly some of these new ones we've been able to get. I'm blown away
by how successful we've been this year, to shift to this kind of number from a very small number last year and get the client
to think that way, because it's hard to break the way you're used to be to proceed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
can tell you just by looking at what's already building pre-RFP season, it's resonating with the clients. So yes, I would say
you look forward to a suite of solutions for every enterprise deal.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
it's pointing&mdash;product number two is really what I'm after here. Is it, oh, patient engagement, that's the next one I want
or, oh, adherence or, oh, digital therapeutics, whatever. What is kind of the next most popular appeal in the product portfolio?
Or is there not?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
think it's sort of a close tie between brand and therapeutic messaging, both are really effective awareness messages for doctors,
and then I would say patient engagement is climbing pretty fast.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
Great. And then I want to come at the outlook from a different angle. You did finish the quarter where you did $8.8 million. Is
the expectation for the third quarter that we'll be sequentially up in the third quarter?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
And then on the Op ex side. Where I've doubled my model the most probably in the last few quarters is on the Op ex. It looks like
this time I got it right, or at least within $100,000. Was there any onetime items that I need to be concerned about for Q3 and
Q4? Or is the $6.2 million on the Op ex a good number to work with?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
you're solid. Yes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doug,
go ahead and add to that.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Douglas
Baker</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Well,
I was just going to say that should be a good number for the rest of the year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We'll
take our next question from Richard Baldry with ROTH Capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Richard
Baldry</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks.
Can you talk about any changes you make to your marketing approach, given the lack of conferences? It seems to go toward&mdash;are
there ways to still reach new prospects or show them what you can do in a broad-based manner? Or is it just very targeted one-to-one
kind of B2B sales efforts that you have to kind of move to now?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex99-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steve,
do you want to handle that one?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stephen
Silvestro</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
I'm happy to speak to it. Can you hear me clearly, okay?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Richard
Baldry</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
it's better.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stephen
Silvestro</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
no worries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hi,
Rich.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">What
we've endeavored to do is really set up an account-based marketing construct within the business that allows us to really proactively
reach out to both new contracts and existing contracts where we have the ability to cross-sell and upsell. It's part of the reason
why we've given such good results, I think, in the first half and why we're very confident about the second half.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basically,
we're able to reach out digitally to these people through various means without the conferences. We've seen very little impact
on top of the funnel marketing qualified lead generation from conferences decreasing, in fact. So it's been a net positive. But
the focus for us is account-based marketing, truly driving into the accounts where we have a good match for our solution, which
we know who those are, and we've shared largely that we've mapped those out.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Richard
Baldry</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
In the first half, you had a really strong ability to sort of guide us through timing and cadence of adding new&mdash;your first
ever new series of enterprise wins. I'm sort of curious how you feel about your visibility on sort of the next slew? Is it wait
until the fall spending decision cycle for pharma to see those? Would they be different in timing: this year they were in the
first half, could they be in the fall of this year? Or do you think it's more still first half of next year to see those again?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I'll
start, Steve, and then you fill in if I forget.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We&rsquo;re
very encouraged by just the beginning of RFP season, which is really&mdash;I mean it really starts now when you're as entrenched
as we are. It will kick off in full swing in September. But if you've got everything together and organized, which we do, you
basically proactively go to your clients with what you can do, what you're doing, why you can do more. And if I look at that activity,
which we're not going to talk pipeline today, I think we'll all be very happy with where we land on pipeline for next year. And
I think it's going to be a really healthy mix of enterprise, tactical, core solutions, patient engagement, and we'll see commitments
prior to year-end. So we'll have better visibility into 2021, at least better than we did the previous year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steve,
anything else to add to that?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex99-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stephen
Silvestro</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No,
I think you covered it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have fairly good visibility even pre-RFP, Rich, having great conversations. We're active. Q3 pipeline looks very strong. As Will
said, we have very good visibility into obviously what we've already sold that is yet to be recognized and additional visibility
into what we will sell in the near term. So more to come on market; feeling very strong.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Richard
Baldry</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">And,
maybe early for this because we're only halfway into 2020, but you talked about being able to hold sort of Op ex in the level
we saw in Q2. When would you expect to see sort of the next level up to support the fast growth that you've had? Is it a 2021
planning that we'll be adding at the beginning of the year to sort of be ready for that next level-up of growth? Or how do we
think about the cadence of Op ex after this year?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
I think we certainly won't be ever greater than our growth, which is a good thing. I would say we will make selective investments
over the next few years, which will support accelerated growth. Right now, it will be&mdash;when you go through as much growth
as we've been through and are seeing, you need to make sure you don't drop any balls, right? You need to make sure your clients
are happy and everything is flowing. If we were to invest, we would probably be investing in cap management and additional commercial
reach. Today, we feel like we've got that team, and we've got a very strong tech team and certainly feel the Executive team is
in order.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
don't anticipate a material change. I guess it could always come from an acquisition if we looked at one later this year or early
next. But operationally, we should start to see more significant drop to the bottom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator
</B></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a reminder, everyone, that is star, one to ask a question.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
next question comes from Alex Silverman with AWM Investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alex
Silverman</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
of my questions have been asked and answered. Just want to confirm one thing. Q3, in a typical season, looks like Q2 from a revenue
standpoint, no?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
that's correct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alex
Silverman</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
All right. So if we use 2Q as a starting point, we're&mdash;and build off that, it's a good exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That's
correct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex99-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alex
Silverman</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
guess on the Op ex side, you guys spent $6.6 million in the first quarter, down to $6.2 million here. And on a go-forward basis,
obviously, there's savings around no travel and such. But I guess I expected you guys to be spending more on investments. Is there
something that we're&mdash;what are we missing there?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.
If you think about our business, it's a platform, right? And when our clients come to us with content that needs to be distributed
on that platform, that is not a complicated task. So you don't need to over-hire to keep up with that type of demand. We also
have a commercial team that has the capability of doing the $100 million revenue run rate business. And we don't need executives,
right? So basically, if you're going to invest, it's going to be to manage the accounts and make sure we're always delighting
the client and servicing our partners, obviously, who are integral to our business.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we could find additional commercial people that would clearly bring a new pharma or enhance a relationship, if there was a partner
that we needed to invest in to get connected to, we will absolutely do that. And if we need to raise money to do it, we'll do
it. If we are going to need to use our cash, we'll do that too. So we're not just sitting back, Alex. It's really a matter of
being very surgical and smart to show that there is scale to this business. And we've got a lot of capacity to go.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alex
Silverman</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Got
it. Okay. And then one last question. What was the earn-out for CareSpeak?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doug,
do you want to take that?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Douglas
Baker</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sure.
As part of the original purchase agreements for both CareSpeak and RMDY, they gain additional contingent consideration if they
hit certain revenue targets. And so the CareSpeak had a revenue target for 2019 that they exceeded, so we paid out that portion
of the earnout. It was additional&mdash;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alex
Silverman</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">And
how much was it?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Douglas
Baker</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roughly
$1.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
next question comes from Harvey Poppel with Poptech, LP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Harvey
Poppel</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Will,
a great, great quarter, hitting on all 16 cylinders. Congratulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Harvey.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex99-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Harvey
Poppel</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
really only have one question. I want to kind of home in on the issue of profitability, which was kind of hit by an implication
in some of the previous questions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your G&amp;A is not going to grow that materially, at least at the pace that it has in the past or in the pace you're setting
for your revenue growth, and your gross margin is going up to the mid-60s heading in that direction, it would seem that pretty
soon you're going to be crossing the GAAP profitability line. Is that a reasonable expectation, at least for some time in 2021?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absolutely.
It's a reasonable expectation. It's the focus. We feel like we're at that time where we can really do that and demonstrate it,
so yes. Just a correction, no, not mid-50s. It's more lower 60s on gross margin, regardless. Yes. I mean we&mdash;yes, probably.
We'll see. If patient engagement scales more, we can get that up to run in the 60s, but that's not going to happen this year.
So yes, absolutely, we want to see it start dropping.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">And
aspirationally, this type of business, if you look at others, many of whom have gone public, you kind of see when they cross that,
Harvey. When you're doing that $50 million to $60 million run rate, you should be dropping 20% to the bottom, if not more. So
that is what we're aiming towards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Harvey
Poppel</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Great.
Just another question kind of around the Livongo-Teladoc deal. If one were to impute the multiple on Livongo, they weren't making
any money, so you really have to look at revenue multiple. And if one were even begin to apply that to OPRX, your stock certainly
looks like it's almost like a fraction of what that deal placed&mdash;the value that was placed on Livongo. Any comment on this?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
Well, yes, I mean it's hard to&mdash;multiples and such are good when they transact because then you know what it really is. I've
been watching all the public comps in our space, and we've been below that, mainly because they're earlier on the curve. We have
a little less retail support as a public entity. But I think this is yet another tailwind to our market because when you deliver
those kind of multiples around the transaction, it attracts a whole ecosphere of investors, institutional, retail, strategic,
international, mutual funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
was really encouraged to see it. Also just happy for those teams. We know them, and I think that will be a good cultural fit and
a really effective digital health company. So I was very encouraged. Very encouraged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We'll
take our next question from Josh Goldberg with G2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Josh
Goldberg</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hi,
Will.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
obviously, there's been an inflection point in your business. And for many years&mdash;or for a few years, you've talked about
pipeline and coverage and some opportunity in terms of like what's going on.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Can
you just talk a little bit, like, is pipeline up 100%? Or obviously, you're saying you're going to accelerate some periods. I
know it's not heroic. You have a very easy compare because of what happened last year. But just in terms of like what you're seeing
in your business because of all these changes with COVID and how squarely positioned you are, I just didn't get a sense so far
on the call of how strong the quarter was in terms of new client engagements and be able to really pick up your business to that
next level.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">And
I have a follow-up.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
Thanks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We&rsquo;re
not doing the pipeline talk yet because it's premature. But it is very safe to say that we will pass the $100 million mark just
based on what we're seeing now. It's absolutely safe to say in terms of pipeline. Everything we mentioned, we're not making up.
And it's so verified out in the open market in terms of digital shift spend, M&amp;A activity, raises. It's a shift, right? You're
looking at a $20 billion to $25 billion spend shift towards digital; and very well understood and documented. So we are absolutely
in the right place. We're seeing it through the dialogue. We can keep up with those dialogues as well. And my hat is off to the
team because they're really doing a good job being proactive with our clients.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Someone
asked what are we doing for marketing that's different because you can't go knock on doors. Those webinars we did, and I'm always
a little skeptical with fluffy stuff, but they absolutely drove credibility and share of voice in our market. And it was a brilliant
move, and we're seeing the benefit, and we'll see it even more. And we will talk to that number when we report Q3 so we can get
into it more specifically.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
hope that gives you a little bit more color.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Josh
Goldberg</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
One last one for me is if you can talk a little bit about&mdash;obviously, you have different products. There are some that are
patient engagement, some of them that are financial.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Which
segment is really doing the best right now? And maybe Steve van pipe in about&mdash;in terms of like really the biggest clients
you have, where are they seeing the real traction in your business?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stephen
Silvestro</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
want me to take that one?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sure.
Sure, go ahead.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stephen
Silvestro</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
Hi, Josh.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
mean we're really seeing, in some of the biggest clients that we have, we're really seeing buying multiple solutions as we sort
of indicated all along. The top pipelines that we have, have really demonstrated what we perceive as a very frothy CAGR over the
last three years coming into the second half of this year. I probably won't share that on the call today, but we will in the near
future. But really, there's multiple solutions; as Will articulated earlier, almost all of them have financial messaging. Many
of them are picking up therapeutic support messaging and brand messaging. We've got several clients on hub enrollment.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<IMG SRC="ex99-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
think what's happening, Josh, is clients are starting to see the ability to manage the interaction as a specifically funnel-like
process. So how do we engage with the physician at the beginning of that patient journey, the physician can get back to the patient
and then carry them through that journey and support them with tools all along so that we don't lose them, we don't have leakage
points or therapy abandonment or prohibition of prescription throughout that process. So it really&mdash;the ones that are driving
the highest amount of revenue have multiple solutions that they're buying. And then they are capitalizing on their ability to
reach in and deliver value across that care continuum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
this time, this concludes our question-and-answer session. I'd now like to turn the call back over to Mr. Febbo. Please go ahead,
sir.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you can take just one thing away from our discussion, although you're probably going to take several positive things, I hope it's
the understanding of our view of very strong growth this year and ability to generate a lot of value for our shareholders because
of our moat, our sustainable strategic advantage and the market tailwinds.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beyond
the numbers, I hope you can see that we've created a unique culture. It's dedicated to something truly valuable, which makes a
difference in people's lives, from patients to physicians and beyond. We do not give guidance as an early stage Company and especially
in this current environment. But given everything you have heard today and what we see, we're very optimistic for a very strong
second half of 2020.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
with that, let's wrap up the call. Thanks, everyone, for your time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
we conclude today's call, I would like to provide the Company's Safe Harbor statement that includes important cautions regarding
forward-looking statements made during today's call.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
made by Management during today's call may contain forward-looking statements within the definition of Section 27A in the Securities
Act of 1993 as amended, in Section 21E at the Securities Act of 1934 as amended. These forward-looking statements should not be
used to make investment decisions. The words anticipate, estimate, expect, possible and seeking and similar expressions identify
forward-looking statements, and they speak only to the date that statements are made.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
forward-looking statements in this call include statements regarding estimation of total addressable market size, market penetration,
revenue growth, gross margin, operating expenses, profitability, cash flow, technology, investments, growth opportunities, acquisitions,
upcoming announcements and the need for raising additional capital. They also include the Management&rsquo;s expectations for
the rest of the year and adoption of the Company's digital health platform. The Company undertakes no obligation to publicly update
or revise any forward-looking statements whether because of new information, future events or otherwise.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and
actual results could differ materially from those set forth in, contemplated by or underlying these forward-looking statements.
The risks and uncertainties to which forward-looking statements are subject to, include, but are not limited to, the effect of
government regulation, competition and other material risks. Risks and uncertainties to which forward-looking statements are subject
to could affect business, and financial results are included in the Company's annual report in Form 10-K for the Fiscal Year ended
December 31, 2019. This form is available on the Company's website and the SEC website at sec.gov.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
we end today's conference, I would like to remind everyone that this call will be available for replay starting later this evening
and running through August 26. Please refer to today's press release for dial-in replay instructions available via the Company's
website at www.optimizerx.com.</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you for joining us today. This concludes today's conference call, and you may now disconnect.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P><P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1-888-562-0262 1-604-929-1352 www.viavid.com</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &_ FP# 2(  A$! Q$!_\0
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MR2%[:'<Z#_A)+/\ YYS_ /?(_P :/^$DL_\ GG/_ -\C_&N>^S?[?Z4?9_\
M;_2CV<@]M#N=#_PDEG_SSG_[Y'^-'_"26?\ SSG_ .^1_C7/?9_]K]*3R/\
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M?<Q0_9-OF.%SYF<9./2MVIE%QW-(5(SUB8_B3_D'1_\ 74?R-4=(_P"/1_\
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M.I,4 -HI<4F*8A*0TZB@!E%.I*8AM)3J2@0E)BEHH 812$8I](13$-I*7%%
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MB@0VDIU%,!E!IU(10(;24[%)3$)24M%,0W%)3J3% A"*3%+10(FL?^0A;?\
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MTNC'^(/Q+D\,:K8Z'HMI'?ZS<NNZ%\[5#<*."/F)Q@>G7J*[O33?-IMNVIK
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ML<#K@(^?T-='X&^)^F>,Y_L/V>2SU)4+F%CN1@.I5N_7H0/QKO*^>H$CT_\
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M4 -I"*=10(CQ13B*0BF(;2&G4A% AM)3L4F*8#:3%.Q24"&TE.Q1B@1)9_\
M'];_ /71?YUUU<E9_P#'];_]=%_G76UC5W1UX;9F/XD_Y!T?_74?R-9.G_\
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MES3:6D ZBDI<T#'44F:,T .HS29I:0[BTN:;2YH =13<TZD,6BDI: "C-%%
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M'3%TZ?9=M!=(\LX*X,K'TX^[ECR:%NK^5_Q_X 24;.W]:+_@G5V?CW6-5O\
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MW>>M4O/R_/7\ 23=OZV_S.M\0^,9]-U>'1=&T676=6D@^TF!)UA6.+.-S.W
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MCJ4&FYI:!C@:=4>:<#2 =2TVEH&.S1FDS10,>#2TP&G4#%I<TVEI .HI*7-
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M#6-!\":?9BX::RU*TBNBT#HL4BC:4+$ $]>!GI7M]+5*Z:;\OP_X ^9:_/\
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MIHI:!CJ6FT9H&.I:;FES2 =2=Z**!BT4E+0 4M)10 M%%%( I:2BF M%%%(
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@IHYD'LV48O\ 7)_O"M.HA;Q*00O(Y')J6I;N:1C8_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J RT# 2(  A$! Q$!_\0
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MR2020,<YCD*EAS_LDCWZT60^9]R[]KO/^>EO_P!^C_\ %4?:KS_GI!_WZ/\
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M5[_?@_[]'_XJC[5>_P!^#_OT?_BJBW4;J+(.9]R7[5>_WX/^_1_^*H^UWO\
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M?X4;=2_Z!=U_W[;_  KT&BCVT@^JP//MNI_] NZ_[]M_A1MU/_H%W7_?MO\
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M_P */M>K_P#0*G_[]/\ X5W%%'M'V#V"[G#_ &O5_P#H%3_]^G_PI?MFK_\
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MG11S^0>Q\SC/[2UG_H$2_P#?IZ/[2UG_ *!$O_?IZ[.BCG\@]CYG&?VEK/\
MT")?^_3T?VEK/_0(E_[]/79T4<_D'L?,X:ZNM7NK:2!M)F"N,$B)\_RKN:**
(4I7+A#E/_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
